Skip to main content
Medical information Clinical review pending

Genetic Testing

HLA DR3 DRB103 Test

The HLA DR3 DRB103 Test identifies genetic markers associated with an increased risk of certain autoimmune diseases, helping understand your immune system's potential responses.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
4 mL (3 mL min.) whole blood in 1 Lavender Top (EDTA) tube OR 6 mL (3 mL min.) whole blood in 1 Yellow Top (ACD) tube.
Results
Approximately 10-12 days. Confirm with the laboratory before booking.
Preparation
No special preparation is required for this blood test. Confirm with the laboratory before booking.
Test priceKSh 12,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the HLA DR3 DRB103 Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Family history of autoimmune diseases
  • ✓Symptoms suggestive of autoimmune conditions (e.g., unexplained fatigue, joint pain, skin rashes)
  • ✓Understanding personal genetic health risks related to immune function
  • ✓Assisting in diagnosis or risk assessment for specific autoimmune disorders
02

In plain language

What this test helps you understand

Identifies genetic markers (HLA DR3 and DRB103 alleles) associated with an increased risk for certain autoimmune diseases. Helps in understanding individual immune system predispositions.
The HLA DR3 DRB103 Test is a genetic assessment used to identify specific Human Leukocyte Antigen (HLA) types. Understanding your HLA type can provide valuable insights into your immune system and potential susceptibility to certain health conditions. This test is particularly relevant for individuals with a family history of autoimmune diseases or those experiencing related symptoms. It measures the presence of the HLA DR3 and DRB103 alleles, which are known genetic markers linked to an increased risk of developing autoimmune disorders. This information can help healthcare providers develop tailored preventive strategies and treatment plans. Early identification of potential risks allows for informed decision-making regarding health management and personalized healthcare approaches based on individual genetic predispositions. Results indicate the presence or absence of these specific alleles. A positive result may suggest a higher risk for certain autoimmune conditions, prompting further discussion with your healthcare provider about appropriate monitoring and preventive measures.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required for this blood test. Confirm with the laboratory before booking.
Sample4 mL (3 mL min.) whole blood in 1 Lavender Top (EDTA) tube OR 6 mL (3 mL min.) whole blood in 1 Yellow Top (ACD) tube.
MethodologyGenetic analysis techniques are used to identify the presence of specific HLA DR3 and DRB103 alleles in the provided blood sample. Confirm with the laboratory before booking.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test identifies genetic predispositions, not definitive diagnoses. A positive result indicates increased risk, but does not guarantee disease development. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

These are specific types of Human Leukocyte Antigens (HLA), which are proteins found on the surface of cells that play a crucial role in the immune system. Certain types, like DR3 and DRB103, are associated with an increased risk of developing specific autoimmune diseases.
Individuals with a family history of autoimmune diseases, those experiencing symptoms like persistent fatigue, joint pain, or skin rashes, or anyone seeking to understand their genetic risk for these conditions may benefit from this test.
A positive result indicates the presence of the HLA DR3 and/or DRB103 alleles. This suggests a potential increased genetic risk for certain autoimmune conditions, but it does not mean you will definitely develop the disease. Discuss the results with your doctor.
No, this test is not diagnostic on its own. It identifies genetic risk factors. A diagnosis requires a comprehensive evaluation by a healthcare professional, including clinical symptoms and other tests.
A simple blood draw is required for this test. The sample is collected in a specific type of tube (Lavender Top/EDTA or Yellow Top/ACD).
The turnaround time is typically around 10-12 days from the time the sample is received by the laboratory. Confirm with the laboratory before booking.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp